Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Quiver Holdings Inc. has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 distinct examiners and 2 distinct art units, indicating examiner-level distribution across a smaller set of technical examination units.
ZARA, JANE J is the busiest examiner, with 1 pending matter. Counsel can coordinate issues within the shared art-unit structure while maintaining separate strategies for each examiner assignment.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §112 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZARA, JANE J | 1 | 71.0% | +16.1% |
| PERSONS, JENNA L | 1 | 50.8% | +61.7% |
| HURST, JONATHAN M | 1 | 53.5% | +19.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18557630 | THERAPEUTIC COMPOSITIONS FOR TREATING PAIN VIA MULTIPLE TARGETS | ZARA, JANE J | — |
| 17740485 | COMPOSITIONS TARGETING SODIUM CHANNEL 1.6 | PERSONS, JENNA L | — |
| 17563385 | PLATE IMAGER | HURST, JONATHAN M | — |
| Art Unit | Apps |
|---|---|
| 1637 | 2 |
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18557630 | THERAPEUTIC COMPOSITIONS FOR TREATING PAIN VIA MULTIPLE TARGETS | ZARA, JANE J | 1637 | §102§112DP | Non-Final OA | — | Pending | Oct 27, 2023 |
| 17740485 | COMPOSITIONS TARGETING SODIUM CHANNEL 1.6 | PERSONS, JENNA L | 1637 | §112 | Non-Final OA | — | Pending | May 10, 2022 |
| 17563385 | PLATE IMAGER | HURST, JONATHAN M | 1799 | §103 | Final Rejection | — | Pending | Dec 28, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialQuiver Holdings Inc. has 3 pending office actions as of October 2026, spread across 2 art units and 3 examiners.
Jane J Zara has the most, with 1 of Quiver Holdings Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
